Kevin Kalinsky, MD, MS, FASCO (@kalinskykevin) 's Twitter Profile
Kevin Kalinsky, MD, MS, FASCO

@kalinskykevin

Division Director of Medical Oncology at Winship/Director Glenn Family Breast Center/Opinions=my own

ID: 1087816554400698379

linkhttps://winshipcancer.emory.edu/bios/faculty/kalinsky-kevin.html calendar_today22-01-2019 20:57:32

190 Tweet

2,2K Followers

150 Following

Clinical Care Options (@cco_education) 's Twitter Profile Photo

Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri 3/21 T-DXd, SG, and Dato-DXd have been tested in phase III trials. All 3 ADCs inhibit topoisomerase I, but there are slight differences in their cytotoxic payloads. #DESTINY-Breast04 #TROPiCS-02 #TROPIONBreast01 Kevin Kalinsky, MD, MS, FASCO #medtwitter #tweetorial #Xtorial

<a href="/KalinskyKevin/">Kevin Kalinsky, MD, MS, FASCO</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/melindatelli/">Melinda Telli, M.D.</a> <a href="/jhaveri_komal/">Komal Jhaveri</a> 3/21 T-DXd, SG, and Dato-DXd have been tested in phase III trials. All 3 ADCs inhibit topoisomerase I, but there are slight differences in their cytotoxic payloads. #DESTINY-Breast04 #TROPiCS-02 #TROPIONBreast01

<a href="/KalinskyKevin/">Kevin Kalinsky, MD, MS, FASCO</a>  #medtwitter #tweetorial #Xtorial
Clinical Care Options (@cco_education) 's Twitter Profile Photo

Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 6/21 âš Unique toxicities associated with T-DXd include ILD. This is an important AE associated with T-DXd that everyone needs to be aware of so that appropriate and careful monitoring and management are performed.

<a href="/KalinskyKevin/">Kevin Kalinsky, MD, MS, FASCO</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/melindatelli/">Melinda Telli, M.D.</a> <a href="/jhaveri_komal/">Komal Jhaveri</a> <a href="/hoperugo/">Hope Rugo</a> <a href="/dradityabardia/">Aditya Bardia, MD</a> <a href="/PTarantinoMD/">Paolo Tarantino</a> 6/21 âš Unique toxicities associated with T-DXd include ILD. This is an important AE associated with T-DXd that everyone needs to be aware of so that appropriate and careful monitoring and management are performed.
Clinical Care Options (@cco_education) 's Twitter Profile Photo

Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 21/21 🎆Thank you for scrolling down this far, following our conversation, and reinforcing your knowledge of ADC for #breastcancer! Go online for more CCO education! clinicaloptions.com/BreastTROP2HER… Thank you to Kevin Kalinsky, MD, MS, FASCO for this #breastcancer #xtorial 🧵 #MedX

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Physicians and scientists from Winship will present new cancer research findings and offer expert perspectives as session leaders at the world's largest clinical cancer research meeting, the 2024 ASCO Annual Meeting in Chicago, May 31 – June 4. #ASCO24 brnw.ch/21wKfFm

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

A new commentary published just in time for Day 1 of #SABCS24 covers past-year top advances in early-stage and metastatic #BreastCancer. Hear from author Kevin Kalinsky, MD, MS, FASCO below & access the article: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert Winship Cancer Institute of Emory University Ruth O'Regan Suresh S. Ramalingam, MD, FASCO

Georgia Society of Clinical Oncology (@gasco_oncology) 's Twitter Profile Photo

FINAL DAYS TO REGISTER The Best of SABCS South is almost here! GASCO Professional Members get a special discounted rate! Don’t wait – secure your spot now. Register here: loom.ly/RaAfTGw

FINAL DAYS TO REGISTER

The Best of SABCS South is almost here! GASCO Professional Members get a special discounted rate! Don’t wait – secure your spot now.

Register here: loom.ly/RaAfTGw
SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

In Journal of Clinical Oncology: A new statistical tool combining clinical and pathologic factors w a patient's 21-gene Recurrence Score® gives more accurate estimates on #breastcancer prognosis & potential chemo benefit than any of the factors alone. #bcsm Yale Cancer Center swog.org/news-events/ne…

In <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>: A new statistical tool combining clinical and pathologic factors w a patient's 21-gene Recurrence Score® gives more accurate estimates on #breastcancer prognosis &amp; potential chemo benefit than any of the factors alone. #bcsm <a href="/YaleCancer/">Yale Cancer Center</a> 
swog.org/news-events/ne…
The Cancer Letter (@thecancerletter) 's Twitter Profile Photo

Tari King appointed chief surgical officer for cancer service line, co-director of Glenn Family Breast Center at Winship Cancer Institute of Emory University, chief of Division of Breast Surgery at Emory cancerletter.com/in-brief/20250…

Tari King appointed chief surgical officer for cancer service line, co-director of Glenn Family Breast Center at <a href="/WinshipAtEmory/">Winship Cancer Institute of Emory University</a>, chief of Division of Breast Surgery at Emory
cancerletter.com/in-brief/20250…